Albuterol HFA Related Published Studies
Well-designed clinical trials related to Albuterol HFA
Active albuterol or placebo, sham acupuncture, or no intervention in asthma. [2011.07.14]
Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses with recurrent airway obstruction. [2011.07]
Efficacy of racemic albuterol versus levalbuterol used as a continuous nebulization for the treatment of acute asthma exacerbations: a randomized, double-blind, clinical trial. [2011.03]
Active albuterol or placebo, sham acupuncture, or no intervention in asthma. [2011]
Efficacy of racemic albuterol versus levalbuterol used as a continuous
nebulization for the treatment of acute asthma exacerbations: a randomized,
double-blind, clinical trial. [2011]
Levalbuterol versuss levalbuterol plus ipratropium in the treatment of severe acute asthma. [2010.12]
A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis. [2010.09]
Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. [2010.08]
Helium/oxygen-driven albuterol nebulization in the management of children with status asthmaticus: a randomized, placebo-controlled trial. [2010.05]
Comparative effects of caffeine and albuterol on the bronchoconstrictor response to exercise in asthmatic athletes. [2010.04]
Repeat dosing of albuterol via metered-dose inhaler in infants with acute obstructive airway disease: a randomized controlled safety trial. [2010.03]
Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease. [2009.12]
Beneficial effects of warmed humidified oxygen combined with nebulized albuterol and ipratropium in pediatric patients with acute exacerbation of asthma in winter months. [2009.11]
Bronchodilator effects of exercise hyperpnea and albuterol in mild-to-moderate asthma. [2009.08]
High-dose continuous nebulized levalbuterol for pediatric status asthmaticus: a randomized trial. [2009.08]
Safety of daily albuterol in infants with a history of bronchospasm: a multi-center placebo controlled trial. [2009.07.16]
Home use of albuterol for asthma exacerbations. [2009.06]
Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium/albuterol MDI *. [2009.03]
The effects of nebulized albuterol on esophageal function in asthmatic patients. [2008.10]
Effects of time, albuterol, and budesonide on the shape of the flow-volume loop in children with asthma. [2008.10]
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. [2008.09]
Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma. [2008.08]
Temporal strength changes from resistance exercise and albuterol on unloaded muscle. [2008.07]
Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations. [2008.07]
Albuterol and exercise effects on ankle extensor strength during 40 days of unloading. [2008.06]
Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast. [2008.06]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Comparison of nebulized epinephrine to albuterol in bronchiolitis. [2008.04]
The Effects of Nebulized Albuterol on Esophageal Function in Asthmatic Patients. [2008.02.13]
Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy. [2008.01.08]
Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2008]
Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study. [2008]
Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma. [2007.12]
An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. [2007.11]
Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction. [2007.09]
Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis. [2007.06.02]
Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. [2007.06]
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. [2007.05.17]
Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2007.01.25]
Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11 years with asthma. [2007]
A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma. [2006.11]
Evaluation of the efficacy and safety of levalbuterol in subjects with COPD. [2006.08]
Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial. [2006.06]
A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. [2006.05]
Assessing the Effects of Racemic and Single-Enantiomer Albuterol on Airway Secretions in Long-term Intubated Patients. [2006.01]
Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial. [2006.01]
Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma. [2005.12]
Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. [2005.11]
Randomized, placebo-controlled trial of albuterol and epinephrine at equipotent beta-2 agonist doses in acute bronchiolitis. [2005.10]
Regular vs ad-lib albuterol for patients hospitalized with acute asthma. [2005.09]
Beneficial effects of albuterol therapy driven by heliox versus by oxygen in severe asthma exacerbation. [2005.09]
Effect of nebulized albuterol on blood glucose in patients with diabetes mellitus with and without cystic fibrosis. [2005.08]
Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children. [2005.07]
A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD. [2005.07]
Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. [2005.07]
Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial. [2005.07]
The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. [2005.05]
Albuterol aids resistance exercise in reducing unloading-induced ankle extensor strength losses. [2005.05]
The study of in vitro-in vivo correlation: pharmacokinetics and pharmacodynamics of albuterol dry powder inhalers. [2005.01]
Comparison of the bronchodilating effects of formoterol and albuterol delivered by hydrofluoroalkane pressurized metered-dose inhaler. [2005]
Well-designed clinical trials possibly related to Albuterol HFA
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus
long-acting beta(2)-agonists for chronic obstructive pulmonary disease. [2012]
Comparison of physician-, biomarker-, and symptom-based strategies for adjustment
of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized
controlled trial. [2012]
Hypertonic saline and acute wheezing in preschool children. [2012]
The use of rhDNAse in severely ill, non-intubated adult asthmatics refractory to
bronchodilators: a pilot study. [2012]
An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with
chronic obstructive pulmonary disease. [2012]
Helium-oxygen therapy for infants with bronchiolitis: a randomized controlled trial. [2011.12]
Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD. [2011.09]
Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea. [2011.09]
Inhaled beta-2 agonist salbutamol for the treatment of transient tachypnea of the newborn. [2011.09]
Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice. [2011.08.15]
Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. [2011.08]
Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD. [2011.08]
[Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children]. [2011.07]
Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. [2011.07]
Evaluation of an alternative chest physiotherapy method in infants with respiratory syncytial virus bronchiolitis. [2011.07]
Long-term safety and efficacy of indacaterol, a long-acting beta-agonist, in subjects with COPD: a randomized, placebo-controlled study. [2011.07]
Advancing donor management research: design and implementation of a large, randomized, placebo-controlled trial. [2011.06.14]
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD. [2011.06]
Randomized controlled trial of a breath-actuated nebulizer in pediatric asthma patients in the emergency department. [2011.06]
Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. [2011.05.31]
Effect of bronchoconstriction on airway remodeling in asthma. [2011.05.26]
Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome. [2011.05.09]
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial. [2011.05.03]
Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study. [2011.05]
The effect of antecedent hypoglycaemia on beta-adrenergic sensitivity in healthy participants with the Arg16Gly polymorphism of the beta-adrenergic receptor. [2011.05]
Lack of protective effect of tiotropium vs induced dynamic hyperinflation in moderate COPD. [2011.05]
Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers. [2011.04]
Inhaled salbutamol plus ipratropium in moderate and severe asthma crises in children. [2011.04]
Tiotropium versus salmeterol for the prevention of exacerbations of COPD. [2011.03.24]
The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol. [2011.03.15]
Comparison of salbutamol efficacy in children--via the metered-dose inhaler (MDI) with Volumatic spacer and via the dry powder inhaler, Easyhaler, with the nebulizer--in mild to moderate asthma exacerbation: a multicenter, randomized study. [2011.03]
Randomized controlled trial to improve care for urban children with asthma: results of the School-Based Asthma Therapy trial. [2011.03]
Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone. [2011.03]
Reported pneumonia in patients with COPD: findings from the INSPIRE study. [2011.03]
Efficacy and cost comparisons of bronchodilatator administration between metered dose inhalers with disposable spacers and nebulizers for acute asthma treatment. [2011.03]
Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. [2011.02.19]
Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. [2011.02.01]
Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control. [2011.02]
The duration of bronchodilation of salmeterol and salbutamol as measured by specific airway conductance in healthy subjects. [2011.02]
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison. [2011.02]
Written action plan in pediatric emergency room improves asthma prescribing, adherence, and control. [2011.01.15]
|
